Federal Register / Vol. 66, No. 113 / Tuesday, June 12, 2001 / Notices 31681

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

NATIONAL CANCER INSTITUTE,

including consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, National Cancer Institute

Subcommittee B—Basic Sciences.

Date: July 9, 2001.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Cancer Institute, Building

31, C Wing, 6th Floor, Conference Room 6,

9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Florence E. Farber, PhD,

Health Scientist Administrator, Institute

Review Office, Office of the Director,

National Cancer Institute, National Institutes

of Health, 6116 Executive Boulevard, Room

7017, Bethesda, MD 20802, 301/496–7628.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalog of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology,

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 4, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14782 Filed 6–11–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the meeting of the

National Cancer Institute Board of

Scientific Advisors.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended to

disclosure information of a personal

nature where disclosure would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Board of Scientific Advisors.

Date: June 25–26, 2001.

Open: June 25, 2001, 8:00 am to 5:30 pm.

Agenda: Director’s Report; Ongoing and

New Business; Reports of Program Review

Group(s); and Budget Presentation; Reports of

Special Initiatives; RFA and RFP Concept

Reviews; and Scientific Presentations.

Place: National Cancer Institute, 9000

Rockville Pike, Building 31, C Wing, 6 Floor,

Conference Room 10, Bethesda, MD 20892.

Closed: June 25, 2001, 5:35 pm to Recess.

Agenda: To review and evaluate personnel

issues.

Place: National Cancer Institute, 9000

Rockville Pike, Building 31, C Wing, 6 Floor,

Conference Room 10, Bethesda, MD 20892.

Open: June 26, 2001, 8:30 am to 1:00 pm.

Agenda: Reports of Special Initiatives; RFA

and RFP Concept Reviews; and Scientific

Presentations.

Place: National Cancer Institute, 9000

Rockville Pike, Building 31, C Wing, 6 Floor,

Conference Room 10, Bethesda, MD 20892.

Contact Person: Paulette S. Gray, Ph.D.,

Executive Secretary, Deputy Director,

Division of Extramural Activities, National

Cancer Institute, National Institutes of

Health, 6116 Executive Boulevard, Room

8141, Bethesda, MD 20892, (301) 496–4218.

This notice is being published less than 15

days prior to the meeting due to the

scheduling conflicts.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

Information is also available on the

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/bsa.htm where

an agenda and any additional information for

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 4, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy, NIH.

[FR Doc. 01–14784 Filed 6–11–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Research Resources Special Emphasis Panel

Biomedical Research Technology.

Date: June 29, 2001.

Time: 1:00 PM to Adjournment.

Agenda: To review and evaluate grant

applications.

Place: Office of Review, National Center for

Research Resources, 6705 Rockledge Drive,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Sybil A. Wellstood, PhD,

Scientific Review Administrator, Office of

Review, National Center for Research

Resources, National Institutes of Health, One

Rockledge Centre, Room 6018, 6705

Rockledge Drive, MSC 7965, Bethesda, MD

20892–7965, (301) 435–0814,

wellstoods@ncrr.nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333;

93.371, Biomedical Technology 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: June 1, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14780 Filed 6–11–01; 8:45 am]

BILLING CODE 4140–01–M